selected publications
-
academic article
-
Low JTChristie MErnst MDumoutier LPreaudet ANi YGriffin MDWMielke LAStrasser APutoczki TLO’Reilly LA. Loss of NFKB1 results in expression of tumor necrosis factor and activation of STAT1 to promote gastric tumorigenesis in mice.
Gastroenterology.
159:1444-1458.e15.
2020
Full text if available -
Alorro MEissmann MMasson FErnst M. Restricted STAT3 inhibition among tumour infiltrating immune cells restricts colorectal tumour growth.
European Journal of Cancer.
138:S61-S61.
2020
Full text if available -
Lalaoui NMerino DGiner GVaillant FChau DLiu LKratina TPal BWhittle JREtemadi NBerthelet JGräsel JHall CRitchie MEErnst MSmyth GKVaux DLVisvader JELindeman GJSilke J. Targeting triple-negative breast cancers with the Smac-mimetic birinapant.
Cell Death and Differentiation.
27:2768-2780.
2020
Full text if available -
Johnstone CNPattison ADHarrison PFPowell DRLock PErnst MAnderson RLBeilharz TH. FGF13 promotes metastasis of triple‐negative breast cancer.
International Journal of Cancer.
147:230-243.
2020
Full text if available -
Poh ARDwyer AREissmann MFChand ALBaloyan DBoon LMurrey MWWhitehead LO'Brien MLowell CAPutoczki TLPixley FJO'Donoghue RJJErnst M. Inhibition of the SRC kinase HCK impairs STAT3-dependent gastric tumor growth in mice.
Cancer immunology research.
8:428-435.
2020
Full text if available -
Janes PWVail MEErnst MScott AM. Eph receptors in the immune-suppressive tumor microenvironment.
Cancer Research.
2020
Full text if available -
Eissmann MFBuchert MErnst M. IL33 and Mast Cells—The Key Regulators of Immune Responses in Gastrointestinal Cancers?.
Frontiers in Immunology.
11:1-11.
2020
Full text if available -
Nguyen PMDagley LFPreaudet ALam NGiam MFung KYAizel Kvan Duijneveldt GTan CWHirokawa YYip HYKLove CGPoh ARCruz ADBurstroem CFeltham RAbdirahman SMMeiselbach KLow RRJPalmieri MErnst MWebb AIBurgess TSieber OMBouillet PPutoczki TL. Loss of Bcl-G, a Bcl-2 family member, augments the development of inflammation-associated colorectal cancer.
Cell Death and Differentiation.
27:742-757.
2020
Full text if available -
Alvarez-Diaz SPreaudet ASamson ALNguyen PMFung KYGarnham ALAlexander WSStrasser AErnst MPutoczki TLMurphy JM. Necroptosis is dispensable for the development of inflammation-associated or sporadic colon cancer in mice.
Cell Death and Differentiation.
2020
Full text if available -
Flanagan DJBarker NDi Constanzo NSMason EAGurney AMeniel VSKoushyar SAustin CRErnst MPearson HBBoussioutas AClevers HPhesse TJVincan E. Frizzled-7 is required for Wnt signalling in gastric tumors with and without Apc mutations.
Cancer Research.
79:970-981.
2019
Full text if available -
Eissmann MFDijkstra CJarnicki APhesse TBrunnberg JPoh AREtemadi NTsantikos EThiem SHuntington NDHibbs MLBoussioutas AGrimbaldeston MABuchert MO'Donoghue RJJMasson FErnst M. IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization.
Nature Communications.
10.
2019
Full text if available -
Thilakasiri PSDmello RSNero TLParker MWErnst MChand AL. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
Seminars in Cancer Biology.
2019
Full text if available -
Thilakasiri PHuynh JPoh ARTan CWNero TLTran KParslow ACAfshar-Sterle SBaloyan DHannan NJBuchert MScott AMGriffin MDWHollande FParker MWPutoczki TLErnst MChand AL. Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth.
EMBO Molecular Medicine.
11.
2019
Full text if available -
Flanagan DBarker NErnst MVincan EPhesse T. The function of Lgr5⁺ cells in the gastric antrum does not require Fzd7 or Myc in vivo.
Biomedicines.
7.
2019
Full text if available -
Huynh JChand AGough DErnst M. Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map.
Nature Reviews: Cancer.
19:82-96.
2019
Full text if available -
Schmidt SSchumacher NSchwarz JTangermann SKenner LSchlederer MSibilia MLinder MAltendorf-Hofmann AKnösel TGruber ESOberhuber GBolik JRehman ASinha ALokau JArnold PCabron ASZunke FBecker-Pauly CPreaudet ANguyen PHuynh JAfshar-Sterle SChand ALWestermann JDempsey PJGarbers CSchmidt-Arras DRosenstiel PPutoczki TErnst MRose-John S. ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.
Journal of Experimental Medicine.
215:1205-1225.
2018
Full text if available -
Doggett KWilliams BBMarkmiller SGeng FSCoates JMieruszynski SErnst MThomas THeath JK. Early developmental arrest and impaired gastrointestinal homeostasis in U12-dependent splicing-defective Rnpc3-deficient mice.
RNA.
24:1856-1870.
2018
Full text if available -
Johnstone CNPattison ADGorringe KLHarrison PFPowell DRLock PBaloyan DErnst MStewart AGBeilharz THAnderson RL. Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer.
Disease Models and Mechanisms.
11.
2018
Full text if available -
Deswaerte VNguyen PWest ABrowning AFYu LRuwanpura SMBalic JLivis TGirard CPreaudet AOshima HFung KYTye HNajdovska MErnst MOshima MGabay CPutoczki TJenkins BJ. Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism.
Cancer Research.
78:1293-1307.
2018
Full text if available -
Eissmann MFDijkstra CWouters MABaloyan DMouradov DNguyen PMDavalos Salas MPutoczki TLSieber OMMariadason JMErnst MMasson F. Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent Manner.
Cancer immunology research.
6:409-421.
2018
Full text if available -
O’Reilly LAPutoczki TLMielke LALow JTLin APreaudet AHerold MJYaprianto KTai LKueh APacini GFerrero RLGugasyan RHu YChristie MWilcox SGrumont RGriffin MDWO’Connor LSmyth GKErnst MWaring PGerondakis SStrasser A. Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner.
Immunity.
48:570-583.e8.
2018
Full text if available -
Sakthianandeswaren AParsons MJMouradov DMacKinnon RNCatimel BLiu SPalmieri MLove CJorissen RNLi SWhitehead LPutoczki TLPreaudet ATsui CNowell CJWard RLHawkins NJDesai JGibbs PErnst MStreet IBuchert MSieber OM. MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors.
Cancer Discovery.
8:988-1005.
2018
Full text if available -
Ziegler PKBollrath JPallangyo CKMatsutani TCanli ÖDe Oliveira TDiamanti MAMüller NGamrekelashvili JPutoczki THorst DMankan AKÖner MGMüller SMüller-Höcker JKirchner TSlotta-Huspenina JTaketo MMReinheckel TDröse SLarner ACWels WSErnst MGreten TFArkan MCKorn TWirth DGreten FR. Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.
Cell.
174:88-101.
2018
Full text if available -
Poh ARErnst M. Targeting Macrophages in Cancer: From Bench to Bedside.
Frontiers in Oncology.
8:1-16.
2018
Full text if available -
Morrow RJEtemadi NYeo BErnst M. Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer.
Mediators of Inflammation.
2017:1-15.
2017
Full text if available -
Alorro MGPierce TPEissmann MFDijkstra CDickins RAErnst MBuchert MMasson F. Generation of an inducible mouse model to reversibly silence Stat3.
Genesis.
55:1-10.
2017
Full text if available -
Poh ARLove CGMasson FPreaudet ATsui CWhitehead LMonard SKhakham YBurstroem LLessene GSieber OLowell CPutoczki TLO'Donoghue RJJErnst M. Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.
Cancer Cell.
31:563-575.e5.
2017
Full text if available -
Ahmed AUYim HCHAlorro MErnst MWilliams BRG. Integrin-Linked Kinase Expression in Myeloid Cells Promotes Inflammatory Signaling during Experimental Colitis.
Journal of Immunology.
199:2128-2139.
2017
Full text if available -
Flanagan DJBarker NNowell CClevers HErnst MPhesse TJVincan E. Loss of the Wnt receptor frizzled 7 in the mouse gastric epithelium is deleterious and triggers rapid repopulation in vivo.
Disease Models and Mechanisms.
10:971-980.
2017
Full text if available -
Huynh JEtemadi NHollande FErnst MBuchert M. The JAK/STAT3 axis: A comprehensive drug target for solid malignancies.
Seminars in Cancer Biology.
45:13-22.
2017
Full text if available -
Coulson RLiew SHConnelly AAYee NSDeb SKumar BVargas ACO’Toole SAParslow ACPoh APutoczki TMorrow RJAlorro MLazarus KAYeap EFWWalton KLHarrison CAHannan NJGeorge AJClyne CDErnst MAllen AMChand AL. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Oncotarget.
8:18640-18656.
2017
Full text if available -
Xin AMasson FLiao YPreston SGuan TGloury ROlshansky MLin J-XLi PSpeed TPSmyth GKErnst MLeonard WJPellegrini MKaech SMNutt SLShi WBelz GTKallies A. A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet.
Nature Immunology.
17:422-432.
2016
Full text if available -
Eissmann MAtapattu LSaha NChheang CEissman MFXu KVail MEHii LLlerena CLiu ZHorvay KAbud HEKusebauch UMoritz RLDing B-SCao ZRafii SErnst MScott AMNikolov DBLackmann MJanes PW. An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth.
Journal of Experimental Medicine.
213:1741-1757.
2016
Full text if available -
Patel ODai WMentzel MGriffin MDWSerindoux JGay YFischer SSterle SKropp ABurns CJErnst MBuchert MLucet IS. Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.
Structure.
24:1550-1561.
2016
Full text if available -
Duan MSteinfort DPSmallwood DHew MChen WErnst MIrving LBAnderson GPHibbs ML. CD11b immunophenotyping identifies inflammatory profiles in the mouse and human lungs.
Mucosal Immunology.
9:550-563.
2016
Full text if available -
Thiem SEissmann MFStuart EElzer JJonas ABuchert MErnst M. Inducible gene modification in the gastric epithelium of Tff1-CreERT2, Tff2-rtTA, Tff3-luc mice.
Genesis.
54:626-635.
2016
Full text if available -
Malaterre JPereira LPutoczki TMillen RPaquet-Fifield SGermann MLiu JCheasley DSampurno SStacker SAAchen MGWard RLWaring PMantamadiotis TErnst MRamsay RG. Intestinal-specific activatable Myb initiates colon tumorigenesis in mice.
Oncogene.
35:2475-2484.
2016
Full text if available -
Poh ARO'Donoghue RJJErnst MPutoczki TL. Mouse models for gastric cancer: Matching models to biological questions.
Journal of Gastroenterology and Hepatology.
31:1257-1272.
2016
Full text if available -
Thiem SEissmann MFElzer JJonas APutoczki TLPoh ANguyen PPreaudet AFlanagan DVincan EWaring PBuchert MJarnicki AErnst M. Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model.
Cancer Research.
76:2277-2287.
2016
Full text if available -
Buchert MBurns CJErnst M. Targeting JAK kinase in solid tumors: emerging opportunities and challenges.
Oncogene.
35:939-951.
2016
Full text if available -
Etemadi NChopin MAnderton HTanzer MCRickard JAAbeysekera WHall CSpall SKWang BXiong YHla TPitson SMBonder CSWong WW-LErnst MSmyth GKVaux DLNutt SLNachbur USilke J. TRAF2 regulates TNF and NF-kappa B signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1.
eLife.
4:1-27.
2015
Full text if available -
Buchert MRohde FEissmann MTebbutt NWilliams BTan CWOwen AHirokawa YGnann AOrend GOrner GDashwood RHHeath JKErnst MJanssen K-P. A hypermorphic epithelial beta-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Disease Models and Mechanisms.
8:1361-1373.
2015
Full text if available -
Johnstone CNChand APutoczki TLErnst M. Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer.
Cytokine and Growth Factor Reviews.
26:489-498.
2015
Full text if available -
Flanagan DJPhesse TJBarker NSchwab RHMAmin NMalaterre JStange DENowell CJCurrie SASaw JTSBeuchert ERamsay RGSansom OJErnst MClevers HVincan E. Frizzled7 Functions as a Wnt Receptor in Intestinal Epithelial Lgr5+ Stem Cells.
Stem Cell Reports.
4:759-767.
2015
Full text if available -
Williams BBTebbutt NCBuchert MPutoczki TLDoggett KBao SJohnstone CNMasson FHollande FBurgess AWScott AMErnst MHeath JK. Glycoprotein A33 deficiency: A new mouse model of impaired intestinal epithelial barrier function and inflammatory disease.
Disease Models and Mechanisms.
8:805-815.
2015
Full text if available -
Poh ARO'Donoghue RJJErnst M. Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.
Oncotarget.
6:15752-15771.
2015
Full text if available -
Putoczki TLErnst M. IL-11 signaling as a therapeutic target for cancer.
Immunotherapy.
7:441-453.
2015
Full text if available -
Ernst MPreaudet APutoczki T. Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice.
Journal of Visualized Experiments.
2015.
2015
Full text if available -
Nguyen PMPutoczki TLErnst M. STAT3-activating cytokines: A therapeutic opportunity for inflammatory bowel disease?.
Journal of Interferon and Cytokine Research.
35:340-350.
2015
Full text if available -
Pearson HBMcGlinn EPhesse TJSchlueter HSrikumar AGoedde NJWoelwer CBRyan APhillips WAErnst MKaur PHumbert P. The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis.
Molecular Cancer.
14:1-16.
2015
Full text if available -
Rickard JAO’Donnell JAEvans JMLalaoui NPoh ARRogers TVince JELawlor KENinnis RLAnderton HHall CSpall SKPhesse TJAbud HECengia LHCorbin JMifsud SDi Rago LMetcalf DErnst MDewson GRoberts AWAlexander WSMurphy JMEkert PGMasters SLVaux DLCroker BAGerlic MSilke J. RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis.
Cell.
157:1175-1188.
2014
Full text if available -
Kennedy CLNajdovska MTye HMcLeod LYu LJarnicki ABhathal PSPutoczki TErnst MJenkins BJ. Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis.
Oncogene.
33:2540-2546.
2014
Full text if available -
Ernst MThiem SNguyen PMEissmann MPutoczki TL. Epithelial gp130/Stat3 functions: An intestinal signaling node in health and disease.
Seminars in Immunology.
26:29-37.
2014
Full text if available -
Humphries JMPenno MASWeiland FKlingler-Hoffmann MZuber ABoussioutas AErnst MHoffmann P. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
BBA: Proteins and Proteomics.
1844:1051-1058.
2014
Full text if available -
Ernst MPutoczki TL. Molecular pathways: IL11 as a tumor-promoting cytokine-translational implications for cancers.
Clinical Cancer Research.
20:5579-5588.
2014
Full text if available -
Phesse TJBuchert MStuart EFlanagan DJFaux MAfshar-Sterle SWalker FZhang HHNowell CJJorissen RTan CWHirokawa YEissmann MFPoh ARMalaterre JPearson HBKirsch DGProvero PPoli VRamsay RGSieber OBurgess AWHuszar DVincan EErnst M. Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration.
Science Signaling.
7:1-12.
2014
Full text if available -
Hare LMPhesse TJWaring PMMontgomery KGKinross KMMills KRoh VHeath JKRamsay RGErnst MPhillips WA. Physiological expression of the PI3K-activating mutation Pik3ca H1047R combines with Apc loss to promote development of invasive intestinal adenocarcinomas in mice.
Biochemical Journal.
458:251-258.
2014
Full text if available -
Ciprotti MChong GGan HKChan AMurone CMacGregor DLee FTJohns TGHeath JKErnst MBurgess AWScott AM. Quantitative intratumoural microdistribution and kinetics of 131I-huA33 antibody in patients with colorectal carcinoma.
EJNMMI Research.
4:1-10.
2014
Full text if available -
Elsum IAYates LLPearson HBPhesse TJLong FO'Donoghue RErnst MCullinane CHumbert PO. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
Oncogene.
33:5523-5533.
2014
Full text if available -
Infantino SJones SAWalker JAMaxwell MJLight AO'Donnell KTsantikos EPeperzak VPhesse TErnst MMackay FHibbs MLFairfax KATarlinton DM. The tyrosine kinase Lyn limits the cytokine responsiveness of plasma cells to restrict their accumulation in mice.
Science Signaling.
7:1-10.
2014
Full text if available -
Stuart EBuchert MPutoczki TThiem SFarid RElzer JHuszar DWaring PMPhesse TJErnst M. Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice.
Molecular Cancer Therapeutics.
13:468-474.
2014
Full text if available -
Carow BReuschl AKGavier-Widén DJenkins BJErnst MYoshimura AChambers BJRottenberg ME. Critical and Independent Role for SOCS3 in Either Myeloid or T Cells in Resistance to Mycobacterium tuberculosis.
PLoS Pathogens.
9:1-20.
2013
Full text if available -
Putoczki TLThiem SLoving ABusuttil RAWilson NJZiegler PKNguyen PMPreaudet AFarid REdwards KMBoglev YLuwor RBJarnicki AHorst DBoussioutas AHeath JKSieber OMPleines IKile BTNash AGreten FRMcKenzie BSErnst M. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.
Cancer Cell.
24:257-271.
2013
Full text if available -
Tsantikos EMaxwell MJPutoczki TErnst MRose-John STarlinton DMHibbs ML. Interleukin-6 trans-signaling exacerbates inflammation and renal pathology in lupus-prone mice.
Arthritis and Rheumatism.
65:2691-2702.
2013
Full text if available -
Thiem SPierce TPPalmieri MPutoczki TLBuchert MPreaudet AFarid ROLove CCatimel BLei ZRozen SGopalakrishnan VSchaper FHallek MBoussioutas ATan PJarnicki AErnst M. mTORC1 inhibition restricts infammation-associated gastrointestinal tumorigenesis in mice.
Journal of Clinical Investigation.
123:767-781.
2013
Full text if available -
Penno MASKlingler-Hoffmann MBrazzatti JABoussioutas APutoczki TErnst MHoffmann P. 2D-DIGE analysis of sera from transgenic mouse models reveals novel candidate protein biomarkers for human gastric cancer.
Journal of Proteomics.
77:40-58.
2012
Full text if available -
Ernst MRamsay RG. Colorectal cancer mouse models: integrating inflammation and the stroma.
Journal of Gastroenterology and Hepatology.
27:39-50.
2012
Full text if available -
Penno MErnst MHoffmann P. Comparative 2D DIGE analysis of the depleted serum proteome for biomarker discovery.
Methods in Molecular Biology.
854:207-220.
2012
Full text if available -
Malaterre JMcPherson CSDenoyer DLai EHagekyriakou JLightowler SShudo KErnst MAshley DMShort JLWheeler GRamsay RG. Enhanced lithium-induced brain recovery following cranial irradiation is not impeded by inflammation.
Stem cells translational medicine.
1:469-479.
2012
Full text if available -
O'Donoghue RJJKnight DARichards CDPrêle CMLau HLJarnicki AGJones JBozinovski SVlahos RThiem SMcKenzie BSWang BStumbles PLaurent GJMcAnulty RJRose-John SZhu HJAnderson GPErnst MRMutsaers SE. Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis.
EMBO Molecular Medicine.
4:939-951.
2012
Full text if available -
Traum DTimothee PSilver JRose-John SErnst MLaRosa DF. IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.
Journal of Leukocyte Biology.
91:427-435.
2012
Full text if available -
Nishina TKomazawa-Sakon SYanaka SPiao XZheng DMPiao JHKojima YYamashina SSano EPutoczki TDoi TUeno TEzaki JUshio HErnst MTsumoto KOkumura KNakano H. Interleukin-11 links oxidative stress and compensatory proliferation.
Science Signaling.
5.
2012
Full text if available -
Greenhill CJGould JErnst MJarnicki AHertzog PJMansell AJenkins BJ. LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling.
Immunology and Cell Biology.
90:559-563.
2012
Full text if available -
Ernst MPutoczki TL. Stat3: Linking inflammation to (gastrointestinal) tumourigenesis.
Clinical and Experimental Pharmacology and Physiology.
39:711-718.
2012
Full text if available -
Greenhill CJRose-John SLissilaa RFerlin WErnst MHertzog PJMansell AJenkins BJ. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
Journal of Immunology.
186:1199-1208.
2011
Full text if available -
Cao YDepinho RAErnst MVousden K. Cancer research: Past, present and future.
Nature Clinical Practice Cardiovascular Medicine.
11:749-754.
2011
Full text if available -
Haroon FDrögemüller KHändel UBrunn AReinhold DNishanth GMueller WTrautwein CErnst MDeckert MSchlüter D. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
Journal of Immunology.
186:6521-6531.
2011
Full text if available -
Silver JSStumhofer JSPassos SErnst MHunter CA. IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii.
Journal of Immunology.
187:350-360.
2011
Full text if available -
Ruwanpura SMMcLeod LMiller AJones JBozinovski SVlahos RErnst MArmes JBardin PGAnderson GPJenkins BJ. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice.
American Journal of Respiratory Cell and Molecular Biology.
45:720-730.
2011
Full text if available -
Sakthianandeswaren AChristie MD'Andreti CTsui CJorissen RNLi SFleming NIGibbs PLipton LMalaterre JRamsay RGPhesse TJErnst MJeffery REPoulsom RLeedham SJSegditsas STomlinson IPMBernhard OKSimpson RJWalker FFaux MCChurch NCatimel BFlanagan DJVincan ESieber OM. PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis.
Cancer Research.
71:3709-3719.
2011
Full text if available -
Itman CWong CHunyadi BErnst MJans DALoveland KL. SMAD3 dosage determines androgen responsiveness and sets the pace of postnatal testis development.
Endocrinology.
152:2076-2089.
2011
Full text if available -
Putoczki TErnst M. More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer.
Journal of Leukocyte Biology.
88:1109-1117.
2010
Full text if available -
Hilfiker-Kleiner DShukla PKlein GSchaefer AStapel BHoch MMüller WScherr MTheilmeier GErnst MHilfiker ADrexler H. Continuous Glycoprotein-130–Mediated Signal Transducer and Activator of Transcription-3 Activation Promotes Inflammation, Left Ventricular Rupture, and Adverse Outcome in Subacute Myocardial Infarction.
Circulation.
122:145-155.
2010
Full text if available -
Kirsch MTrautmann NErnst MHofmann H-D. Involvement of gp130-associated cytokine signaling in Müller cell activation following optic nerve lesion.
Glia.
58:768-779.
2010
Full text if available -
Pereira-Fantini PMJudd LMKalantzis APeterson AErnst MHeath JKGiraud AS. A33 antigen-deficient mice have defective colonic mucosal repair.
Inflammatory Bowel Diseases.
16:604-612.
2010
Full text if available -
Mejías-Luque RLindén SKGarrido MTye HNajdovska MJenkins BJIglesias MErnst Mde Bolós C. Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors.
Oncogene.
29:1753-1762.
2010
Full text if available -
Buchert MAthineos DAbud HEBurke ZDFaux MCSamuel MSJarnicki AGWinbanks CENewton IPMeniel VSSuzuki HStacker SANäthke ISTosh DHuelsken JClarke ARHeath JKSansom OJErnst M. Genetic Dissection of Differential Signaling Threshold Requirements for the Wnt/β-Catenin Pathway In Vivo.
PLoS Genetics.
6:e1000816-e1000816.
2010
Full text if available -
Jarnicki APutoczki TErnst M. Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?.
Cell Division.
5:14-14.
2010
Full text if available -
Ciznadija DTothill RWaterman MLZhao LHuynh DYu RMErnst MIshii SMantamadiotis TGonda TJRamsay RGMalaterre J. Intestinal adenoma formation and MYC activation are regulated by cooperation between MYB and Wnt signaling.
Cell Death and Differentiation.
16:1530-1538.
2009
Full text if available -
Penno MASErnst MHoffmann P. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides.
Rapid Communications in Mass Spectrometry.
23:2656-2662.
2009
Full text if available -
Samuel MSSuzuki HBuchert MPutoczki TLTebbutt NCLundgren–May TChristou AInglese MToyota MHeath JKWard RLWaring PMErnst M. Elevated Dnmt3a Activity Promotes Polyposis in ApcMin Mice by Relaxing Extracellular Restraints on Wnt Signaling.
Gastroenterology.
137:902-913.e11.
2009
Full text if available -
Steinberg GRWatt MJErnst MBirnbaum MJKemp BEJorgensen SB. Ciliary Neurotrophic Factor Stimulates Muscle Glucose Uptake by a PI3-Kinase-Dependent Pathway That Is Impaired With Obesity.
Diabetes.
58:829-839.
2009
Full text if available -
Howlett MGiraud ASLescesen HJackson CBKalantzis AVan Driel IRRobb LVan der Hoek MErnst MMinamoto TBoussioutas AOshima HOshima MJudd LM. The Interleukin-6 Family Cytokine Interleukin-11 Regulates Homeostatic Epithelial Cell Turnover and Promotes Gastric Tumor Development.
Gastroenterology.
136:967-977.e3.
2009
Full text if available -
Bollrath JPhesse TJvon Burstin VAPutoczki TBennecke MBateman TNebelsiek TLundgren-May TCanli ÖSchwitalla SMatthews VSchmid RMKirchner TArkan MCErnst MGreten FR. gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis.
Cancer Cell.
15:91-102.
2009
Full text if available -
Nowell MAWilliams ASCarty SAScheller JHayes AJJones GWRichards PJSlinn SErnst MJenkins BJTopley NRose-John SJones SA. Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis.
Journal of Immunology.
182:613-622.
2009
Full text if available -
Fielding CAMcLoughlin RMMcLeod LColmont CSNajdovska MGrail DErnst MJones SATopley NJenkins BJ. IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT3.
Journal of Immunology.
181:2189-2195.
2008
Full text if available -
Ernst MNajdovska MGrail DLundgren-May TBuchert MTye HMatthews VBArmes JBhathal PSHughes NRMarcusson EGKarras JGNa SSedgwick JDHertzog PJJenkins BJ. STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
Journal of Clinical Investigation.
118:1727-1738.
2008
Full text if available -
Walker FZhang H-HMatthews VWeinstock JNice ECErnst MRose-John SBurgess AW. IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF– and GM-CSF–deficient mice.
Blood.
111:3978-3985.
2008
Full text if available -
Dierssen UBeraza NLutz HHLiedtke CErnst MWasmuth HETrautwein C. Molecular Dissection of gp130-dependent Pathways in Hepatocytes during Liver Regeneration.
Journal of Biological Chemistry.
283:9886-9895.
2008
Full text if available -
Stumhofer JSSilver JSLaurence APorrett PMHarris THTurka LAErnst MSaris CJMO'Shea JJHunter CA. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.
Nature Immunology.
8:1363-1371.
2007
Full text if available -
Brender CTannahill GMJenkins BJFletcher JColumbus RSaris CJMErnst MNicola NAHilton DJAlexander WSStarr R. Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27.
Blood.
110:2528-2536.
2007
Full text if available -
Flentjar NChu PNg AYJohnstone CNHeath JKErnst MHertzog PJPritchard MA. TGF-βRII Rescues Development of Small Intestinal Epithelial Cells in Elf3-Deficient Mice.
Gastroenterology.
132:1410-1419.
2007
Full text if available -
Jenkins BJRoberts AWGreenhill CJNajdovska MLundgren-May TRobb LGrail DErnst M. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis.
Blood.
109:2380-2388.
2007
Full text if available -
Malaterre JCarpinelli MErnst MAlexander WCooke MSutton SDworkin SHeath JKFrampton JMcArthur GClevers HHilton DMantamadiotis TRamsay RG. c-Myb is required for progenitor cell homeostasis in colonic crypts.
Proceedings of the National Academy of Sciences of USA.
104:3829-3834.
2007
Full text if available -
Boireau SBuchert MSamuel MSPannequin JRyan JLChoquet AChapuis HRebillard XAvancès CErnst MJoubert DMottet NHollande F. DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.
Carcinogenesis.
28:246-258.
2007
Full text if available -
Yeoh GCTErnst MRose-John SAkhurst BPayne CLong SAlexander WCroker BGrail DMatthews VB. Opposing roles of gp130-mediated STAT-3 and ERK-1/2 signaling in liver progenitor cell migration and proliferation.
Hepatology.
45:486-494.
2007
Full text if available -
Samuel MSSamuel MSLundgren-May TErnst M. Identification of putative targets of DNA (cytosine-5) methylation-mediated transcriptional silencing using a novel conditionally active form of DNA methyltransferase 3a.
Growth Factors.
25:426-436.
2007
Full text if available -
Kiu HHilton DJNicola NAErnst MMarquez RAlexander WSRoberts AWMcmanus EJ. Mechanism of crosstalk inhibition of IL-6 signaling in response to LPS and TNFα.
Growth Factors.
25:319-328.
2007
Full text if available -
Pietrangelo ADierssen UValli LGaruti CRump ACorradini EErnst MKlein CTrautwein C. STAT3 Is Required for IL-6-gp130–Dependent Activation of Hepcidin In Vivo.
Gastroenterology.
132:294-300.
2007
Full text if available -
El Kasmi KCHolst JCoffre MMielke Lde Pauw ALhocine NSmith AMRutschman RKaushal DShen YSuda TDonnelly RPMyers MGAlexander WVignali DAAWatowich SSErnst MHilton DJMurray PJ. General Nature of the STAT3-Activated Anti-Inflammatory Response.
Journal of Immunology.
177:7880-7888.
2006
Full text if available -
Judd LMBredin KKalantzis AJenkins BJErnst MGiraud AS. STAT3 Activation Regulates Growth, Inflammation, and Vascularization in a Mouse Model of Gastric Tumorigenesis.
Gastroenterology.
131:1073-1085.
2006
Full text if available -
Stumhofer JSLaurence AWilson EHHuang ETato CMJohnson LMVillarino AVHuang QYoshimura ASehy DSaris CJMO'Shea JJHennighausen LErnst MHunter CA. Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system.
Nature Immunology.
7:937-945.
2006
Full text if available -
Stuhlmann-Laeisz CLang SChalaris AKrzysztof PEnge SEichler JKlingmüller USamuel MErnst MRose-John SScheller J. Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem Cells.
Molecular Biology of the Cell.
17:2986-2995.
2006
Full text if available -
Watt MJDzamko NThomas WGRose-John SErnst MCarling DKemp BEFebbraio MASteinberg GR. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.
Nature Medicine.
12:541-548.
2006
Full text if available -
Emery BMerson TDSnell CYoung KMErnst MKilpatrick TJ. SOCS3 negatively regulates LIF signaling in neural precursor cells.
Molecular and Cellular Neuroscience.
31:739-747.
2006
Full text if available -
Vlahos RBozinovski SGualano RCErnst MAnderson GP. Modelling COPD in mice.
Pulmonary Pharmacology and Therapeutics.
19:12-17.
2006
Full text if available -
Howlett MJudd LMJenkins BLa Gruta NLGrail DErnst MGiraud AS. Differential Regulation of Gastric Tumor Growth by Cytokines That Signal Exclusively Through the Coreceptor gp130.
Gastroenterology.
129:1005-1018.
2005
Full text if available -
Jenkins BJGrail DNheu TNajdovska MWang BWaring PInglese MMcLoughlin RMJones SATopley NBaumann HJudd LMGiraud ASBoussioutas AZhu H-JErnst M. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling.
Nature Medicine.
11:845-852.
2005
Full text if available -
McLoughlin RMJenkins BJGrail DWilliams ASFielding CAParker CRErnst MTopley NJones SA. IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.
Proceedings of the National Academy of Sciences of USA.
102:9589-9594.
2005
Full text if available -
Sims NAJenkins BJNakamura AQuinn JMWLi RGillespie MTErnst MRobb LMartin TJ. Interleukin-11 Receptor Signaling Is Required for Normal Bone Remodeling.
Journal of Bone and Mineral Research.
20:1093-1102.
2005
Full text if available -
Jenkins BJRoberts AWNajdovska MGrail DErnst M. The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis.
Blood.
105:3512-3520.
2005
Full text if available -
Klein CWüstefeld TAssmus URoskams TRose-John SMüller MManns MPErnst MTrautwein C. The IL-6–gp130–STAT3 pathway in hepatocytes triggers liver protection in T cell–mediated liver injury.
Journal of Clinical Investigation.
115:860-869.
2005
Full text if available -
Palmer JErnst MHammacher AHertzog PJ. Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo.
The Prostate.
62:282-289.
2005
Full text if available -
O Donoghue RJJAnderson GPBozinovski SJones JErnst MKnight DAMutsaers SE. Directed Gp130-Mediated Signaling Dissociates Inflammation from Fibrosis in Bleomycin Induced Lung Injury.
Inflammation Research.
54:S215-S216.
2005
Full text if available -
Zhao LHart SCheng JMelenhorst JJBierie BErnst MStewart CSchaper FHeinrich PCUllrich ARobinson GWHennighausen L. Mammary Gland Remodeling Depends on gp130 Signaling through Stat3 and MAPK.
Journal of Biological Chemistry.
279:44093-44100.
2004
Full text if available -
Jenkins BJGrail DInglese MQuilici CBozinovski SWong PErnst M. Imbalanced gp130-Dependent Signaling in Macrophages Alters Macrophage Colony-Stimulating Factor Responsiveness via Regulation of c-fms Expression.
Molecular and Cellular Biology.
24:1453-1463.
2004
Full text if available -
Sims NAJenkins BJQuinn JMWNakamura AGlatt MGillespie MTErnst MMartin TJ. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.
Journal of Clinical Investigation.
113:379-389.
2004
Full text if available -
Ernst M. Acquiring signalling specificity from the cytokine receptor gp130.
Trends in Genetics.
20:23-32.
2004
Full text if available -
Judd LMAlderman BMHowlett MShulkes ADow CMoverley JGrail DJenkins BJErnst MGiraud AS. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130.
Gastroenterology.
126:196-207.
2004
Full text if available -
Kaczmarczyk SJAndrikopoulos SFavaloro JDomenighetti AADunn AErnst MGrail DFodero-Tavoletti MHuggins CEDelbridge LMZajac JDProietto J. Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy.
Journal of Molecular Endocrinology.
31:449-459.
2003
Full text if available -
Knight DAErnst MAnderson GPMoodley YPMutsaers SE. The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression?.
Pharmacology and Therapeutics.
99:327-338.
2003
Full text if available -
Wong PKKCampbell IKEgan PJErnst MWicks IP. The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover.
Arthritis and Rheumatism.
48:1177-1189.
2003
Full text if available -
Johnstone CChang LMErnst MW. AACR special meeting in cancer research: colon cancer--genetics to prevention.
Cancer Research.
62:6779-6783.
2002
-
Ernst MWJenkins B. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling.
Experimental Hematology.
30:1248-1256.
2002
Full text if available -
Tebbutt NCGiraud ASInglese MJenkins BWaring PClay FJMalki SAlderman BMGrail DHollande FHeath JKErnst M. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.
Nature Medicine.
8:1089-1097.
2002
Full text if available -
Johnstone CNWhite SJTebbutt NCClay FJErnst MBiggs WHViars CSCzekay SArden KCHeath JK. Analysis of the Regulation of the A33 Antigen Gene Reveals Intestine-specific Mechanisms of Gene Expression.
Journal of Biological Chemistry.
277:34531-34539.
2002
Full text if available -
Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR. Constitutive Activation of the Src Family Kinase Hck Results in Spontaneous Pulmonary Inflammation and an Enhanced Innate Immune Response.
Journal of Experimental Medicine.
196:589-604.
2002
Full text if available -
Orner GADashwood W-MBlum CADı́az GDLi QAl-Fageeh MTebbutt NHeath JKErnst MDashwood RH. Response of Apcmin and A33ΔNβ-cat mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Mutation Research.
506-507:121-127.
2002
Full text if available -
Butzkueven HZhang J-GSoilu-Hanninen MHochrein HChionh FShipham KAEmery BTurnley AMPetratos SErnst MBartlett PFKilpatrick TJ. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival.
Nature Medicine.
8:613-619.
2002
Full text if available -
Orner GADashwood WMLi QJAl-Fageeh MTebbutt NHeath JKErnst MWDahswood RH. Cellular effects of tea antioxidants in vitro and in mouse models of colorectal cancer: Modulation of Wnt signalling.
Free Radical Research.
36:16-20.
2002
-
Ernst MInglese MWaring PCampbell IKBao SClay FJAlexander WSWicks IPTarlinton DMNovak UHeath JKDunn AR. Defective Gp130-Mediated Signal Transducer and Activator of Transcription (Stat) Signaling Results in Degenerative Joint Disease, Gastrointestinal Ulceration, and Failure of Uterine Implantation.
Journal of Experimental Medicine.
194:189-204.
2001
Full text if available -
Lafage-Proust M-HWesolowski GErnst MRodan GARodan SB. Retinoic acid effects on an SV-40 large T antigen immortalized adult rat bone cell line.
Journal of Cellular Physiology.
179:267-275.
1999
Full text if available -
Ernst MNovak UNicholson SELayton JEDunn AR. The Carboxyl-terminal Domains of gp130-related Cytokine Receptors Are Necessary for Suppressing Embryonic Stem Cell Differentiation.
Journal of Biological Chemistry.
274:9729-9737.
1999
Full text if available -
Clay FJErnst MRTrueman JWHFlegg RDunn AR. The mouse Plk gene: structural characterization, chromosomal localization and identification of a processed Plk pseudogene.
Gene.
198:329-339.
1997
Full text if available -
Starr RNovak UWillson TAInglese MMurphy VAlexander WSMetcalf DNicola NAHilton DJErnst M. Distinct Roles for Leukemia Inhibitory Factor Receptor α-Chain and gp130 in Cell Type-specific Signal Transduction.
Journal of Biological Chemistry.
272:19982-19986.
1997
Full text if available -
Gendall ARDunn ARErnst M. Isolation and characterization of a leukemia inhibitory factor-independent embryonic stem cell line.
The International Journal of Biochemistry and Cell Biology.
29:829-840.
1997
Full text if available -
Ernst MOates ADunn AR. gp130-mediated Signal Transduction in Embryonic Stem Cells Involves Activation of Jak and Ras/Mitogen-activated Protein Kinase Pathways.
Journal of Biological Chemistry.
271:30136-30143.
1996
Full text if available -
Ernst MGearing DPDunn AR. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells..
The EMBO Journal.
13:1574-1584.
1994
Full text if available -
Ernst MParker MGRodan GA. Functional Estrogen Receptors in Osteoblastic Cells Demonstrated by Transfection with a Reporter Gene Containing an Estrogen Response Element.
Molecular Endocrinology.
5:1597-1606.
1991
Full text if available -
Ernst MRodan GA. Estradiol Regulation of Insulin-Like Growth Factor-I Expression in Osteoblastic Cells: Evidence for Transcriptional Control.
Molecular Endocrinology.
5:1081-1089.
1991
Full text if available -
Suva LJErnst MRodan GA. Retinoic acid increases zif268 early gene expression in rat preosteoblastic cells..
Molecular and Cellular Biology.
11:2503-2510.
1991
Full text if available -
ERNST MRODAN GA. Increased Activity of Insulin-Like Growth Factor (IGF) in Osteoblastic Cells in the Presence of Growth Hormone (GH): Positive Correlation with the Presence of the GHInduced IGF-Binding Protein BP-3.
Endocrinology.
127:807-814.
1990
Full text if available -
Ernst MSchmid CFroesch ER. Phenol red mimics biological actions of estradiol: Enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo.
Journal of Steroid Biochemistry.
33:907-914.
1989
Full text if available -
ERNST MHEATH JKRODAN GA. Estradiol Effects on Proliferation, Messenger Ribonucleic Acid for Collagen and Insulin-like Growth Factor-I, and Parathyroid Hormone-Stimulated Adenylate Cyclase Activity in Osteoblastic Cells from Calvariae and Long Bones.
Endocrinology.
125:825-833.
1989
Full text if available -
Schmid CErnst MZapf JRFroesch ER. Release of insulin-like growth factor carrier proteins by osteoblasts: Stimulation by estradiol and growth hormone.
Biochemical and Biophysical Research Communications.
160:788-794.
1989
Full text if available -
Ernst MHeath JKSchmid CFroesch RERodan GA. Evidence for a direct effect of estrogen on bone cells in vitro.
Journal of Steroid Biochemistry.
34:279-284.
1989
Full text if available -
Ernst MSchmid CFroesch ER. Enhanced osteoblast proliferation and collagen gene expression by estradiol..
Proceedings of the National Academy of Sciences of USA.
85:2307-2310.
1988
Full text if available -
Ernst MFroesch ER. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I.
Biochemical and Biophysical Research Communications.
151:142-147.
1988
Full text if available -
Ernst MFroesch ER. Triiodothyronine stimulates proliferation of osteoblast-like cells in serum-free culture.
FEBS Letters.
220:163-166.
1987
Full text if available -
Ernst MFroesch ER. Osteoblastlike cells in a serum-free methylcellulose medium form colonies: Effects of insulin and insulinlike growth factor I.
Calcified Tissue International.
40:27-34.
1987
Full text if available -
Hausman REDobi ETWoodford EJPetrides SErnst MNichols EB. Prostaglandin binding activity and myoblast fusion in aggregates of avian myoblasts.
Developmental Biology.
113:40-48.
1986
Full text if available -
Ernst MEppenberger HDoetschman T. Initial appearance of myomesin in differentiating muscle cells.
Cell Differentiation.
13:319-323.
1983
Full text if available
-
Low JTChristie MErnst MDumoutier LPreaudet ANi YGriffin MDWMielke LAStrasser APutoczki TLO’Reilly LA. Loss of NFKB1 results in expression of tumor necrosis factor and activation of STAT1 to promote gastric tumorigenesis in mice.
Gastroenterology.
159:1444-1458.e15.
2020
-
conference paper
-
Huber ADijkstra CErnst MEissmann M. DNA methyltransferases drive gastric cancer growth and present a therapy target for gastric cancer..
Cancer Research.
2020
-
Huber ADijkstra CErnst MEissmann M. DNA methyltransferases drive gastric cancer growth and present a therapy target for gastric cancer.
European Journal of Cancer.
S43-S43.
2020
Full text if available -
Eissmann MDijkstra CErnst M. Interleukin 33: A new target against gastrointestinal cancer?.
European Journal of Cancer.
S60-S60.
2020
Full text if available -
Thilakasiri PNero TParker MWErnst MChand AL. Repurposing bazedoxifene to suppress gastrointestinal cancer growth.
Cancer Research.
2019
Full text if available -
Ernst MRChand AHuntington NO'Donoghue RPoh A. Targeting the myeloid-cell specific SRC-kinase HCK improves anti-tumor immunity.
Cancer Research.
2019
Full text if available -
Huynh JChand AErnst M. IL-11 as a therapeutic target to treat colorectal cancer.
Cancer Research.
2018
Full text if available -
Atapattu LSaha NChheang CVail MEissman MErnst MScott ANikolov DJanes P. Selective inhibition of notch signalling and cancer stem cells by an antibody targeting active ADAM10.
European Journal of Cancer.
S194-S194.
2016
Full text if available
-
Huber ADijkstra CErnst MEissmann M. DNA methyltransferases drive gastric cancer growth and present a therapy target for gastric cancer..
Cancer Research.
2020
-
conference poster
-
editorial article
-
Ernst MO'Donoghue RJPoh AR. Targeting H(i)ck education for cancer therapy.
Oncoscience.
4:11-12.
2017
Full text if available -
Ernst MPutoczki T. IL-17 cuts to the chase in colon cancer.
Immunity.
41:880-882.
2014
Full text if available -
Ernst MPutoczki TL. Targeting IL-11 signaling in colon cancer.
Oncotarget.
4:1860-1861.
2013
Full text if available
-
Ernst MO'Donoghue RJPoh AR. Targeting H(i)ck education for cancer therapy.
Oncoscience.
4:11-12.
2017
-
erratum
-
Etemadi NChopin MAnderton HTanzer MCRickard JAAbeysekera WHall CSpall SKWang BXiong YHla TPitson SMBonder CSWong WW-LErnst MSmyth GKVaux DLNutt SLNachbur USilke J. Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1.
eLife.
1-4.
2017
Full text if available
-
Etemadi NChopin MAnderton HTanzer MCRickard JAAbeysekera WHall CSpall SKWang BXiong YHla TPitson SMBonder CSWong WW-LErnst MSmyth GKVaux DLNutt SLNachbur USilke J. Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1.
eLife.
1-4.
2017